Custom antibody biotin conjugation for whole antibodies, IgG, IgM, antibody fragments, and secondary detection probes. Biotinylated antibody reagents support ELISA, Western blot, immunohistochemistry, flow cytometry, capture assays, and streptavidin-based detection workflows.
Antibody biotin conjugation involves the covalent attachment of biotin molecules to antibodies or antibody fragments to enable highly versatile detection, capture, and amplification strategies. Biotinylated antibodies are widely used in ELISA, Western blot, immunohistochemistry, flow cytometry, and affinity-based assay systems.
Biotin labeling allows antibodies to interact with streptavidin or avidin-based systems, enabling modular assay design, strong signal amplification potential, and adaptable detection workflows across multiple platforms. This approach is especially valuable when one antibody needs to be paired with multiple downstream reporters or assay architectures.
Formats
Primary to secondary
Whole antibodies, Ig classes, fragments, and secondary detection probe formats
Binding
Ultra-high affinity
Biotin-streptavidin interaction supports stable and reliable assay design
Design
Linker configurable
Short, long, and PEG-based spacer options can affect accessibility and performance
Use
Capture to amplification
Useful in detection, enrichment, pull-down, capture, and flexible downstream readout
Antibody biotin conjugation can be applied to multiple antibody and probe formats depending on the intended assay design, detection strategy, and downstream workflow.
Biotin conjugation of full-length antibodies for detection, capture, immobilization, and flexible streptavidin-based assay workflows.
Biotinylation of IgG antibodies for ELISA, Western blot, immunohistochemistry, flow cytometry, and other analytical applications.
Biotin labeling of IgM antibodies for class-specific assay systems and specialized detection formats.
Biotin conjugation of Fab, F(ab')2, and related fragment formats for applications requiring reduced steric hindrance or altered binding presentation.
Biotinylated primary antibodies for direct target recognition followed by streptavidin-based detection or signal development.
Biotinylated secondary detection probes for indirect assay workflows, signal amplification, and flexible downstream reporter selection.
The biotin–streptavidin interaction is one of the strongest known non-covalent biological interactions, with extremely high affinity. This makes biotinylated antibody systems valuable for stable binding, practical assay assembly, and reliable downstream detection.
In many workflows, a biotinylated antibody first binds its target antigen. A streptavidin-conjugated detection reagent is then introduced to generate signal or support capture. This two-step architecture often provides more flexibility than direct labeling because the same biotinylated antibody can be combined with multiple downstream reporter types.
Provide minimal spacing between the antibody and biotin. Useful when compact labeling is preferred, though accessibility may be more limited in some assay environments.
Improve accessibility of biotin to streptavidin when steric hindrance is a concern, especially in crowded or complex sample systems.
Can improve solubility and reduce non-specific interactions. Often considered for sensitive assays or workflows that benefit from improved flexibility and spacing.
NHS-ester biotin reagents are commonly used to label accessible primary amines on antibodies, especially lysine residues. This is one of the most widely used strategies for antibody biotinylation.
Thiol-reactive biotin reagents can be used when sulfhydryl groups are available or intentionally introduced for more specialized conjugation strategies.
The best conjugation chemistry depends on antibody format, required labeling density, linker type, assay architecture, and the intended downstream application.
Select a biotinylation approach based on antibody format, desired spacer length, and downstream application goals.
Align linker and spacer design to steric accessibility, solubility requirements, and practical assay behavior.
Plan the biotinylated reagent around the intended downstream reporter system, whether enzyme-based, fluorescent, or affinity-driven.
Support use cases where biotinylated antibodies are part of capture, enrichment, immobilization, or affinity isolation workflows.
Support biotin conjugation strategies that are aligned to the final assay system rather than a generic labeling workflow.
Support project-specific biotinylation needs where reagent format, detection method, or capture architecture define the design.
Biotinylated antibodies for capture and detection systems used with streptavidin-based reporters.
Biotin-streptavidin detection workflows for flexible enzyme or fluorescent reporting formats.
Biotin-based tissue detection workflows using avidin or streptavidin-mediated signal generation.
Biotinylated antibody systems compatible with streptavidin-fluorophore detection formats.
Capture, pull-down, enrichment, and immobilization workflows based on biotin-affinity systems.
Biotinylated reagents for modular assay development, optimization, and platform integration.
It is the covalent attachment of biotin to an antibody or related detection reagent so it can be used in streptavidin- or avidin-based systems.
They enable stable, high-affinity binding to streptavidin, flexible assay design, and strong detection or capture workflows.
Short linkers, longer spacer arms, and PEG-based linkers may be used depending on accessibility, steric requirements, and assay goals.
Whole antibodies, IgG, IgM, antibody fragments such as Fab or F(ab')2, and secondary detection probes can all be biotinylated depending on project needs.
They are commonly paired with streptavidin- or avidin-conjugated enzymes, fluorophores, or other reporter systems.
Biotinylated antibodies are widely used in ELISA, Western blot, immunohistochemistry, flow cytometry, affinity capture workflows, and diagnostic assay development.
For the fastest quote, include the antibody format, intended use, need for capture or detection, preferred linker type if known, and the streptavidin- or avidin-based workflow you plan to use.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.